PROSTATIC SPECIFIC ANTIGEN ABNORMAL

This adverse event was reported 1038 times

These drugs are most commonly taken by patients reporting PROSTATIC SPECIFIC ANTIGEN ABNORMAL:

# Drug Count
0 LEUPROLIDE ACETATE 448
1 ENZALUTAMIDE 201
2 ABIRATERONE ACETATE 103
3 BICALUTAMIDE 70
4 RELUGOLIX 52
5 DENOSUMAB 47
6 PREDNISONE 41
7 ASPIRIN 40
8 ASPIRIN 81 MG 39
9 ASPIRIN 325 MG 38
See all common drugs associated with PROSTATIC SPECIFIC ANTIGEN ABNORMAL

PROSTATIC SPECIFIC ANTIGEN ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEGARELIX 35 0.0066
1 LEUPROLIDE ACETATE 448 0.0057
2 CABAZITAXEL 20 0.0057
3 BICALUTAMIDE 70 0.0046
4 ENZALUTAMIDE 201 0.0034
5 APALUTAMIDE 31 0.0026
6 RADIUM RA 223 DICHLORIDE 13 0.0026
7 ABIRATERONE ACETATE 103 0.0025
8 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 24 0.0017
9 FEBUXOSTAT TABLETS 40 MG 13 0.0012
See all drugs enriched for association with PROSTATIC SPECIFIC ANTIGEN ABNORMAL

PROSTATIC SPECIFIC ANTIGEN ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Androgen Receptor Inhibitor [EPC] 249 0.0034
1 Radioligand Therapeutic Agent [EPC] 24 0.0017
2 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 21 0.0010
3 Autologous Cellular Immunotherapy [EPC] 3 0.0005
4 Oxytocic [EPC] 1 0.0003
5 RANK Ligand Inhibitor [EPC] 47 0.0002
6 Potassium-sparing Diuretic [EPC] 3 0.0002
7 Androgen [EPC] 6 0.0002
8 Cholinesterase Inhibitor [EPC] 4 0.0002
9 Ergot Derivative [EPC] 1 0.0002
See all drug classes enriched for association with PROSTATIC SPECIFIC ANTIGEN ABNORMAL